Related references
Note: Only part of the references are listed.Su1696 Efficacy of Second-Line Treatment for Helicobacter pylori Infection: Moxifloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy
Kwang Hyun Chung et al.
GASTROENTEROLOGY (2015)
Su1715 Substitution of Tetracycline by Amoxicillin in Second-Line Helicobacter pylori Treatment Conveys Comparable Success Rates
Spyridon Michopoulos et al.
GASTROENTEROLOGY (2015)
Su1695 Levofloxacin, Metronidazole and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second Line Treatment of Helicobacter pylori Infection
Ji Yoon Moon et al.
GASTROENTEROLOGY (2015)
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption
Francis Megraud et al.
GUT (2013)
Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report
Peter Malfertheiner et al.
GUT (2012)
Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate
Marco Manfredi et al.
HELICOBACTER (2012)
Maintenance of Helicobacter pylori Eradication Rates with Triple Therapy Over 12 Years in a Spanish hospital
Javier P. Gisbert et al.
HELICOBACTER (2012)
Randomized Comparison of Two Non-Bismuth-Containing Second-line Rescue Therapies for Helicobacter pylori
Seng-Kee Chuah et al.
HELICOBACTER (2012)
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
Javier P. Gisbert et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2012)
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Randomized Comparison of Two Nonbismuth-Containing Rescue Therapies for Helicobacter pylori
Tsung-Hui Hu et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Helicobacter pylori infection: Is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients
R. Urgesi et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Rescue therapy after Helicobacter pylori eradication failure
Javier P. Gisbert
GASTROENTEROLOGIA Y HEPATOLOGIA (2011)
Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
Jun-Won Chung et al.
HELICOBACTER (2011)
Quadruple Therapy with Medications Containing Either Rufloxacin or Furazolidone as a Rescue regimen in the Treatment of Helicobacter pylori-Infected Dyspepsia Patients: A Randomized Pilot Study
Li-Yang Gu et al.
HELICOBACTER (2011)
Efficacy of 2-Week, Second-Line Helicobacter pylori Eradication Therapy Using Rabeprazole, Amoxicillin, and Metronidazole for the Japanese Population
Kazutoshi Hori et al.
HELICOBACTER (2011)
Triple Therapy with Ecabet Sodium, Amoxicillin and Lansoprazole for 2 Weeks as the Rescue Regimen for H. pylori Infection
Takahisa Furuta et al.
INTERNAL MEDICINE (2011)
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial
Jyh-Ming Liou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection
Hyuk Yoon et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
Peter Malfertheiner et al.
LANCET (2011)
Helicobacter pylori Infection A Randomized, Controlled Study Comparing 2 Rescue Therapies After Failure of Standard Triple Therapies
Deng-Chyang Wu et al.
MEDICINE (2011)
Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer
Fatih Ermis et al.
SOUTHERN MEDICAL JOURNAL (2011)
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area
J. Yakoob et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2010)
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin
J. P. Gisbert et al.
DIGESTIVE AND LIVER DISEASE (2010)
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice
Stefano Pontone et al.
DIGESTIVE AND LIVER DISEASE (2010)
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design
Jyh-Ming Liou et al.
GUT (2010)
Bismuth-Containing Quadruple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
Byoung Hwan Lee et al.
HELICOBACTER (2010)
Rabeprazole Can Overcome the Impact of CYP2C19 Polymorphism on Quadruple Therapy
Chao-Hung Kuo et al.
HELICOBACTER (2010)
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
Yuqin Li et al.
WIENER KLINISCHE WOCHENSCHRIFT (2010)
Cumulative H-pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen
Theodore Rokkas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
H-pylori Treatment: New Wine in Old Bottles?
Nimish Vakil
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Sequential Therapy or Triple Therapy for Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children
Luigi Gatta et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
M1059 Impact of Efficacies of Triple Therapy Using Lafutidine Plus Amoxicillin-Metronidazole for Proton Pump Inhibitor-Amoxicillin-Clarithromycin Treatment Failures for Helicobacter pylori Infection
Takahiko Kudo et al.
GASTROENTEROLOGY (2009)
Impact of Quadruple Regimen of Clarithromycin Added to Metronidazole-Containing Triple Therapy Against Helicobacter pylori Infection Following Clarithromycin-Containing Triple-Therapy Failure
Nobue Ueki et al.
HELICOBACTER (2009)
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
Chao-Hung Kuo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis
J. L. Tong et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2009)
Second-line rescue therapy with levofloxacin after H-Pylori treatment failure: A Spanish multicenter study of 300 patients
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Meta-analysis: Sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment
Nadim S. Jafri et al.
ANNALS OF INTERNAL MEDICINE (2008)
Treatment of Helicobacter pylori infection
Brian J. Egan et al.
HELICOBACTER (2008)
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection
Kazunari Murakami et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Rescue regimens after Helicobacter pylori treatment failure
Javier P. Gisbert
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Empirical rescue therapy after Helicobacter pylori treatment failure:: a 10-year single-centre study of 500 patients
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Second-line treatment for Helicobacter pylori infection:: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy
Jung Mook Kang et al.
HELICOBACTER (2007)
Levofloxacin-based triple therapy for Helicobacter pylori re-treatment:: Role of bacterial resistance
F. Perna et al.
DIGESTIVE AND LIVER DISEASE (2007)
Helicobacter pylori and antibiotic resistance
Francis Megraud
GUT (2007)
Evolution of Helicobacter pylori therapy from a meta-analytical perspective
Javier P. Gisbert et al.
HELICOBACTER (2007)
The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis
Angelo Zullo et al.
GUT (2007)
Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy
Naohito Shirai et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Levofloxacin-vs. ranitidine bismuth citrate-containing therapy after H-pylori treatment failure
Javier P. Gisbert et al.
HELICOBACTER (2007)
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H-pylori
T. Furuta et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori
Toshihiro Nishizawa et al.
DIGESTION (2007)
Randomized comparison of two rescue therapies for Helicobacter pylori infection
D. C. Wu et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection
Kazunari Murakami et al.
HELICOBACTER (2006)
A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures
Yi-Chia Lee et al.
HELICOBACTER (2006)
Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility
Jae Hee Cheon et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori infection in the Japanese population:: A multicenter study in the Tokyo metropolitan area
T Matsuhisa et al.
HELICOBACTER (2006)
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection:: A meta-analysis
RJ Saad et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection
JH Cheon et al.
HELICOBACTER (2006)
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Levofloxacin-versus metronidazole-based rescue therapy for H-pylori infection in Japan
Y Matsumoto et al.
DIGESTIVE AND LIVER DISEASE (2005)
Helicobacter pylori rescue therapy after failure of two eradication treatments
JP Gisbert et al.
HELICOBACTER (2005)
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients
AS Köksal et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Comparison of two management strategies for Helicobacter pylori treatment: Clinical study and cost-effectiveness analysis
D Marko et al.
HELICOBACTER (2005)
Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H-Pylori after failed therapy
AW Kao et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2005)
Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation
S Gallinger et al.
GASTROENTEROLOGY (2004)
H pylori antibiotic resistance:: prevalence, importance, and advances in testing
F Mégraud
GUT (2004)
Second-line treatment for Helicobacter pylori infection in Japan:: proton pump inhibitor-based amoxicillin and metronidazole regimen
A Nagahara et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Helicobacter pylori infection in Turkish children:: Comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication
F Özçay et al.
HELICOBACTER (2004)
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population
T Shimoyama et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'
F Perri et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy
Y Watanabe et al.
DIGESTIVE AND LIVER DISEASE (2003)
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment:: a randomized trial
EC Nista et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori
CH Chi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection
H Isomoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?
H Miwa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance
K Murakami et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan
I Miki et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2003)
The effect of Helicobacter pylori retreatment with ranitidine bismuth citrate, clarithromycin, and metronidazole depends on the first-line therapy
PG Farup et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection
D Boixeda et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies
SD Georgopoulos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
A triple therapy regimen after failed Helicobacter pylori treatments
A Zullo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection
A Nagahara et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Therapeutic strategies in Helicobacter pylori infection
X Calvet et al.
MEDICINA CLINICA (2001)
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy
N Magaret et al.
DIGESTIVE DISEASES (2001)
High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy
B Sicilia et al.
MEDICINA CLINICA (2000)
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole:: a meta-analysis of eradication of Helicobacter pylori
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
A 10-days PPI/AM regimen is significantly effective as secondline treatment in unsuccessfully treated patients by firstline PPI/AC regimens.
A Nagahara et al.
GASTROENTEROLOGY (2000)
Helicobacter pylori eradication therapy.: The Spanish Consensus Report
JP Gisbert et al.
MEDICINA CLINICA (2000)
Regular review - Treatment of Helicobacter pylori infection
WA de Boer et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
